Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2011) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Trends in Pharmacological Sciences | journal | 5.422 Q1 | 244 | 90 | 249 | 6986 | 2845 | 232 | 11.29 | 77.62 |  |
| 2 | Nature Reviews Drug Discovery | journal | 6.281 Q1 | 391 | 225 | 603 | 6565 | 6481 | 465 | 9.54 | 29.18 | |
| 3 | Natural Product Reports | journal | 3.285 Q1 | 211 | 82 | 218 | 15034 | 1973 | 209 | 9.13 | 183.34 | |
| 4 | Particle and Fibre Toxicology | journal | 2.760 Q1 | 119 | 34 | 94 | 1594 | 799 | 90 | 8.89 | 46.88 | |
| 5 | Neuropsychopharmacology | journal | 4.150 Q1 | 249 | 254 | 807 | 17601 | 6542 | 771 | 7.85 | 69.30 | |
| 6 | Drug Discovery Today | journal | 1.928 Q1 | 215 | 139 | 444 | 8041 | 3049 | 410 | 6.59 | 57.85 | |
| 7 | Critical Reviews in Toxicology | journal | 1.939 Q1 | 129 | 36 | 125 | 5090 | 716 | 116 | 5.88 | 141.39 | |
| 8 | Clinical Pharmacokinetics | journal | 1.861 Q1 | 184 | 61 | 180 | 3425 | 1157 | 165 | 5.84 | 56.15 | |
| 9 | Expert Opinion on Drug Delivery | journal | 1.689 Q1 | 133 | 111 | 295 | 11234 | 1677 | 290 | 5.70 | 101.21 | |
| 10 | Nanotoxicology | journal | 1.654 Q1 | 107 | 61 | 91 | 2635 | 509 | 88 | 5.53 | 43.20 | |
| 11 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.326 Q1 | 99 | 24 | 80 | 3831 | 424 | 75 | 5.23 | 159.63 | |
| 12 | Neuropharmacology | journal | 2.293 Q1 | 191 | 323 | 771 | 20594 | 3973 | 758 | 5.18 | 63.76 | |
| 13 | Toxicological Sciences | journal | 1.890 Q1 | 207 | 292 | 853 | 16284 | 4345 | 800 | 4.89 | 55.77 | |
| 14 | Expert Opinion on Investigational Drugs | journal | 1.541 Q1 | 117 | 142 | 487 | 11009 | 2256 | 471 | 4.88 | 77.53 | |
| 15 | Journal of Antimicrobial Chemotherapy | journal | 2.341 Q1 | 221 | 562 | 1565 | 14529 | 7510 | 1220 | 4.76 | 25.85 | |
| 16 | Current Opinion in Drug Discovery and Development | journal | 1.565 Q1 | 85 | 0 | 215 | 0 | 1005 | 203 | 4.75 | 0.00 | |
| 17 | International Journal of Neuropsychopharmacology | journal | 1.998 Q1 | 125 | 116 | 370 | 6709 | 1789 | 343 | 4.47 | 57.84 | |
| 18 | CNS Neuroscience and Therapeutics | journal | 1.437 Q1 | 91 | 83 | 118 | 6890 | 558 | 110 | 4.46 | 83.01 | |
| 19 | Pharmacogenomics Journal | journal | 1.494 Q1 | 95 | 49 | 144 | 2213 | 668 | 140 | 4.42 | 45.16 | |
| 20 | Expert Opinion on Biological Therapy | journal | 1.312 Q1 | 102 | 141 | 459 | 11869 | 1848 | 452 | 4.34 | 84.18 | |
| 21 | Environmental Pollution | journal | 2.041 Q1 | 301 | 486 | 1446 | 23044 | 6236 | 1425 | 4.17 | 47.42 | |
| 22 | Expert Opinion on Therapeutic Targets | journal | 1.575 Q1 | 106 | 112 | 352 | 10954 | 1340 | 348 | 4.13 | 97.80 | |
| 23 | BioDrugs | journal | 1.486 Q1 | 79 | 48 | 120 | 2573 | 568 | 114 | 4.12 | 53.60 | |
| 24 | Journal of Nanobiotechnology | journal | 1.142 Q1 | 109 | 57 | 58 | 2106 | 277 | 58 | 4.11 | 36.95 | |
| 25 | BMC Chemical Biology | journal | 1.979 Q1 | 21 | 2 | 17 | 74 | 73 | 17 | 4.07 | 37.00 | |
| 26 | Expert Opinion on Emerging Drugs | journal | 0.973 Q2 | 54 | 45 | 135 | 5658 | 526 | 135 | 3.97 | 125.73 | |
| 27 | Expert Review of Vaccines | journal | 1.405 Q1 | 105 | 167 | 435 | 11738 | 1689 | 350 | 3.91 | 70.29 | |
| 28 | Current Opinion in Molecular Therapeutics | journal | 1.475 Q1 | 67 | 0 | 236 | 0 | 885 | 224 | 3.86 | 0.00 | |
| 29 | Expert Opinion on Therapeutic Patents | journal | 1.129 Q1 | 88 | 112 | 329 | 9333 | 991 | 320 | 3.86 | 83.33 | |
| 30 | Current Opinion in Investigational Drugs | journal | 1.423 Q1 | 83 | 0 | 406 | 0 | 1554 | 382 | 3.82 | 0.00 | |
| 31 | Drug Safety | journal | 1.803 Q1 | 140 | 96 | 306 | 4277 | 1205 | 243 | 3.78 | 44.55 | |
| 32 | Food and Chemical Toxicology | journal | 1.124 Q1 | 203 | 501 | 1592 | 21016 | 5906 | 1561 | 3.55 | 41.95 | |
| 33 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.018 Q1 | 100 | 120 | 369 | 11161 | 1500 | 365 | 3.53 | 93.01 | |
| 34 | Pharmacogenomics | journal | 1.213 Q1 | 100 | 164 | 556 | 8344 | 2055 | 456 | 3.45 | 50.88 | |
| 35 | Tetrahedron | journal | 1.473 Q1 | 236 | 1196 | 3799 | 59894 | 13155 | 3772 | 3.40 | 50.08 | |
| 36 | ChemMedChem | journal | 1.267 Q1 | 119 | 235 | 640 | 9505 | 2264 | 626 | 3.29 | 40.45 | |
| 37 | Alcohol and Alcoholism | journal | 1.066 Q2 | 109 | 119 | 302 | 4362 | 905 | 276 | 3.24 | 36.66 | |
| 38 | Mutagenesis | journal | 1.092 Q1 | 102 | 102 | 201 | 5209 | 789 | 191 | 3.22 | 51.07 | |
| 39 | Bioorganic and Medicinal Chemistry | journal | 1.137 Q1 | 187 | 787 | 2774 | 30152 | 9178 | 2766 | 3.21 | 38.31 | |
| 40 | Journal of Psychopharmacology | journal | 1.194 Q1 | 135 | 166 | 501 | 10159 | 1617 | 451 | 3.18 | 61.20 | |
| 41 | Antiviral Therapy | journal | 1.515 Q1 | 93 | 155 | 424 | 5436 | 1631 | 415 | 3.16 | 35.07 | |
| 42 | Human Genomics | journal | 1.126 Q1 | 68 | 36 | 89 | 1912 | 262 | 75 | 3.08 | 53.11 | |
| 43 | Toxicology in Vitro | journal | 0.846 Q2 | 125 | 266 | 723 | 11245 | 2207 | 716 | 3.08 | 42.27 | |
| 44 | BMC Clinical Pharmacology | journal | 0.639 Q2 | 43 | 23 | 47 | 722 | 141 | 47 | 3.06 | 31.39 | |
| 45 | British Journal of Clinical Pharmacology | journal | 1.220 Q1 | 167 | 240 | 706 | 8650 | 2304 | 539 | 3.05 | 36.04 | |
| 46 | Tetrahedron Letters | journal | 1.217 Q1 | 181 | 1736 | 5369 | 60571 | 16024 | 5368 | 3.01 | 34.89 | |
| 47 | Expert Opinion on Pharmacotherapy | journal | 0.800 Q2 | 93 | 259 | 847 | 18824 | 2415 | 814 | 2.99 | 72.68 | |
| 48 | Toxicon | journal | 0.908 Q2 | 144 | 212 | 885 | 9582 | 2504 | 864 | 2.89 | 45.20 | |
| 49 | Journal of Drug Targeting | journal | 0.978 Q1 | 107 | 98 | 255 | 3654 | 802 | 245 | 2.83 | 37.29 | |
| 50 | Bioorganic and Medicinal Chemistry Letters | journal | 1.122 Q1 | 166 | 1516 | 4384 | 40378 | 12616 | 4382 | 2.81 | 26.63 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data